Search Results - "Montuoro, A"

Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography by Waldstein, S M, Faatz, H, Szimacsek, M, Glodan, A-M, Podkowinski, D, Montuoro, A, Simader, C, Gerendas, B S, Schmidt-Erfurth, U

“…Purpose To compare signal penetration depth and deep structure-visualization of swept source (SS) and spectral domain (SD)-optical coherence tomography (OCT)…”
Get full text

Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft by Gaziev, J, Sodani, P, Lucarelli, G, Polchi, P, Marktel, S, Paciaroni, K, Marziali, M, Isgrò, A, Simone, M D, Roveda, A, Montuoro, A, Lanti, A, Alfieri, C, De Angelis, G, Gallucci, C, Ciceri, F, Roncarolo, M G

“…There is a substantial incidence of graft failure in patients with thalassemia after myeloablative conditioning regimens especially in class 3 patients in whom…”
Get full text

Autologous bone marrow transplantation as consolidation therapy in newly diagnosed non-Hodgkin's lymphoma: long-term outcome by Montuoro, A, Lalle, M, Ingletto, D

“…Autologous bone marrow transplantation (ABMT) often produces durable remission in patients with intermediate-high grade non-Hodgkin's lymphoma (NHL). We…”
Get more information

Autologous Bone Marrow Transplantation in Relapses of Chemotherapy-Sensitive Aggressive Non-Hodgkin's Lymphoma: Long-Term Outcome by Lalle, M., Montuoro, A.

“…Eleven patients with relapsed intermediate to high grade non-Hodgkin's lymphoma (NHL) responding to induction treatment were treated with high-dose…”
Get full text

Therapy of 'high risk' myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1,25-dihydroxyvitamin D3 by De Rosa, L, Montuoro, A, De Laurenzi, A

“…Forty-four patients with high risk primary myelodysplastic syndromes and an excess of marrow blasts were treated with a combination of low-dose Ara-C, retinoic…”
Get more information

Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients by Casassus, P, Gibson, J, Joshua, DE, Matthews, J, Diaz, JC, Gertz, MA, Kyle, R, Leong, T, Oken, MM, Fritz, E, Ludwig, H, Corrado, C, Lastiri, F, Peest, D, Grosbois, B, Vela-Ojeda, J, Avvisati, G, Mandelli, F, Petrucci, MT, Capnist, G, Child, JA, Drayson, MT, Dunn, J, MacLennan, I, Mellstedt, H, Osterborg, A, Rodjer, S, Turesson, I, Westin, J, Bergsagel, D, Browman, GP, Shustik, C, Zee, B, Hjorth, M, Holmberg, E, Alison, R, Clarke, M, Elphinstone, P, Evans, V, Gray, R, Hicks, C, James, S, MacKinnon, L, Peto, R, Richards, S, Wheatley, K, Blade, J, Fontanillas, M, San Miguel, J, Aitchison, R, Newland, AC, Cunningham, D, Malpas, J, Powles, RL, Montuoro, A, Jacobson, J, Salmon, S

“…Many randomized trials have evaluated α‐interferon as myeloma therapy, some suggesting a benefit and others not. Most were too small to give reliable answers,…”
Get full text

Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies by De Rosa, L, Montuoro, A, Pandolfi, A, Lanti, T, Pescador, L, Morara, R, De Laurenzi, A

“…In this report we describe the use of the immunomagnetic depletion of tumor cells from harvested bone marrow in two patients with acute lymphoblastic leukemia…”
Get more information

Progenitor cells purging: negative selection by De Rosa, L, Montuoro, A, Pandolfi, A, Paladini, U, Lanti, T, Morara, R, De Laurenzi, A

“…Disease relapse after autologous bone marrow transplantation (ABMT) may arise from residual tumor in the recipient and/or from cancer cells that are reinfused…”
Get more information

A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent by Montuoro, A, De Rosa, L, Del Monte, C, Blandino, F, Pandolfi, A, Lanti, T, De Laurenzi, A

“…Various methods have been investigated to concentrate hemopoietic stem cells before in vitro treatment and cryopreservation. Each procedure requires various…”
Get more information

Blood stem cells autografts in patients with high risk multiple myeloma by Montuoro, A, De Rosa, L, Zoli, V, Pandolfi, A, Cossutta, M, Lanti, T, De Laurenzi, A

“…Five patients with high risk multiple myeloma not responsive to standard chemotherapy were treated by high-dose chemotherapy (Melphalan, Cyclophosphamide)…”
Get more information

Survival after PBSC transplantation and comparison of engraftment speed with autologous and allogeneic marrow transplantation: results of a multicenter study by Iacone, A, Pierelli, L, Quaglietta, A M, Nicolucci, A, Menichella, G, Di Bartolomeo, P, De Laurenzi, A, Fioritoni, G, Indovina, A, Leone, G

“…We have analyzed the results of a multicenter study on peripheral blood stem cell transplantation (PBSCT) performed on 55 patients suffering from various…”
Get more information

Blood stem cell autografts in patients with high risk multiple myeloma by De Rosa, L, Montuoro, A, Zoli, V, Lanti, T, Cossutta, M, De Laurenzi, A

Get more information

Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia by Tura, Sante, Baccarani, Michele, Zuffa, Eliana, Russo, Domenico, Fanin, Renato, Zaccaria, Alfonso, Fiacchini, Mauro

“…Chronic myeloid leukemia (CML) was treated for many years with radiation and with chemotherapy, mainly busulfan and hydroxyurea. Since that treatment neither…”
Get full text

Prognostic factors in myelodysplastic syndromes with excess of blasts. A multivariate analysis by De Rosa, L, Montuoro, A, Del Monte, C, Mancusi, L, De Laurenzi, A

Get more information

Immunological evaluation after haematopoietic stem cell transplantation for beta-thalassaemia by Marziali, M, Isgro, A, Gaziev, J, Fraboni, D, Sodani, P, Paciaroni, K, Gallucci, C, Montuoro, A, Polchi, P, Roveda, A, Lucarelli, G

“…Background: Haematopoietic stem cell transplantation (HSCT) remains the only curative option for patients with thalassemia. After HSCT is particularly…”
Get full text

Low-dose amphotericin B lipid complex or liposomal amphotericin B prophylaxis of invasive fungal infections in children following stem cell transplantation for haemoglobinopathies by Gaziev, J, Alfieri, C, Marziali, M, Isgro, A, Sodani, P, Polchi, P, Simone, M.D, Gallucci, C, Paciaroni, K, Roveda, A, De Angelis, G, Montuoro, A, Lucarelli, G

“…Invasive fungal infection (IFI) is a leading cause of non relapse mortality in allogeneic SCT recipients. This is the first study evaluating low-dose…”
Get full text

Aberrations of chromosome No. 1 in blastic phase of chronic myeloid leukemia by Alimena, G, Dallapiccola, B, Mitelman, F, Montuoro, A

Get more information

Autologous blood stem cell collection after chemotherapy in patients with sensitive and refractory malignancies: a multicenter retrospective study by Pierelli, L, Iacone, A, Quaglietta, A M, Nicolucci, A, Menichella, G, Benedetti Panici, P, De Laurenzi, A, De Rosa, L, Fioritoni, G, Indovina, A

“…A retrospective study was undertaken to assess the factors affecting the yield of peripheral blood stem cell (PBSC) collections after chemotherapy. Fifty-five…”
Get more information

Stem cell transplantation in sickle cell anaemia by De Angelis, G, Gallucci, C, Paciaroni, K, Alfieri, C, Isgro, A, Marziali, M, Roveda, A, Simone, M, Montuoro, A, Sodani, P, Polchi, P, Wakama, T, Gaziev, J, Lucarelli, G

“…Objectives: Stem Cell Transplantation (SCT) is the only definitive cure for Sickle Cell Anemia (SCA). We report the outcomes of SCT from HLA-matched related…”
Get full text

A peculiar case of relapse followed by remission after bone marrow transplantation for chronic myeloid leukemia by De Laurenzi, A, Petti, N, Pescarollo, A, De Rosa, L, Montuoro, A, Pacilli, L, Ruscio, C, Zoli, V

Get more information